Weight-Loss drug tested as surprise depression treatment
NCT ID NCT07136714
First seen Jan 10, 2026 · Last updated May 19, 2026 · Updated 20 times
Summary
This study tests whether semaglutide, a drug used for diabetes and weight loss, can improve mood in 116 people with major depression who are also overweight or obese. Participants will receive either semaglutide or a placebo once a week for 26 weeks, in addition to their usual depression medications. The main goal is to see if depressive symptoms decrease more with semaglutide than with placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mental Health Centre North Zealand
RECRUITINGHillerød, Denmark, 3400, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.